Jane Street’s Kura Oncology KURA Stock Holding History

Jane Street’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$410K	Buy	37,400 +1,300	+4%	+$12.3K	﹤0.01%	8492
2026 Q1	$293K	Buy	+36,100	New	+$310K	﹤0.01%	9279
2025 Q4	–	Sell	-15,400	Closed	-$136K	–	11824
2025 Q3	$136K	Buy	+15,400	New	+$110K	﹤0.01%	9951
2022 Q1	–	Sell	-13,400	Closed	-$188K	–	10691
2021 Q4	$188K	Buy	13,400 +1,100	+9%	+$17.8K	﹤0.01%	8859
2021 Q3	$230K	Buy	+12,300	New	+$232K	﹤0.01%	8646
2021 Q1	–	Sell	-41,000	Closed	-$1.34M	–	9378
2020 Q4	$1.34M	Sell	41,000 -35,000	-46%	-$1.23M	﹤0.01%	4191
2020 Q3	$2.33M	Buy	+76,000	New	+$1.68M	﹤0.01%	2805

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Jane Street's KURA Position: Q2 2026 in Review

Jane Street reduced its Kura Oncology (KURA) stake by 89% in Q2 2026, selling an estimated $5.56M and leaving 74,383 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #6962.

Jane Street first reported a position in KURA in Q2 2019 and has held it in 24 quarters since. The position peaked at $5.39M in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Jane Street held 74,383 shares of Kura Oncology worth $816K as of Q2 2026.
Jane Street sold 588,967 Kura Oncology shares in Q2 2026, an estimated $5.56M.
Kura Oncology made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6962 holding.
Jane Street first reported a position in Kura Oncology in Q2 2019 and has held it in 24 quarters since.
Jane Street's Kura Oncology position peaked at $5.39M in Q1 2026.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.